TVM Capital Healthcare has announced a USD 35 million investment in Boston Oncology Arabia, a bio-generic drugs manufacturer based in Saudi Arabia. Headquartered in Riyadh with a production facility in Sudair Industrial City, Boston Oncology Arabia focuses on locally developing…
Technology Holdings, a global investment bank with offices in North America, Europe, and Asia-Pacific, has acted as the exclusive financial advisor to Design + Industry in its strategic sale to Capgemini. Design + Industry, founded in 1987 and based in…
ResearchAndMarkets.com is pleased to announce the addition of the “Innovations in Flow Cytometry & Extracellular Vesicles 2024” conference to its offerings. Bringing together researchers and industry participants from academia and industry alike, this established event will focus on the latest…
Xeno Biosciences Inc., a company focused on advancing therapies for obesity and metabolic diseases, has initiated a Phase 1b clinical study to evaluate the efficacy, safety, and tolerability of its drug candidate XEN-101 in obese adults. This study aims to…
Takeda (TSE:4502/NYSE) unveiled encouraging findings from its Phase 2b study, which evaluated mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare bleeding disorder caused by accelerated platelet destruction. Presented at the 32nd Congress of the…
The “U.S. Electronic Medical Records (EMR) Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. Post this:The U.S. Electronic Medical Records (EMR) Market reached USD 5.92 billion in 2023 and is projected to grow to USD 8.10…
Alcon (SIX/NYSE: ALC), a global leader in eye care, has received U.S. FDA 510(k) clearance for its UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS). These advancements mark the debut of Alcon’s anticipated Unity portfolio. “We have a…
Cerus Corporation (Nasdaq) announced today its participation in the 38th International Congress of the International Society of Blood Transfusion (ISBT) in Barcelona, Spain, from June 23 to June 27. This global event gathers experts and professionals in transfusion medicine. Key…
“Bristol Myers Squibb (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRAZATI® (adagrasib) in combination with cetuximab as a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic…
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech firm dedicated to eliminating amyotrophic lateral sclerosis (ALS), has leveraged Esri’s mapping technology to introduce the ALS Trial Navigator. This innovative tool aims to simplify the process for ALS patients…
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology under the Omnipod® brand, has unveiled positive outcomes from its pivotal trial of the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for type 2 diabetes at the American…
OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on treatments for obesity and associated disorders, has unveiled new data for its liver-targeted mitochondrial protonophore, TLC-6740, at the 84th Scientific Sessions of the American Diabetes Association in Orlando, Fla. The company will…